Carroll Financial Associates’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$298K Sell
3,408
-50
-1% -$4.37K 0.02% 323
2021
Q3
$282K Sell
3,458
-560
-14% -$45.7K 0.02% 331
2021
Q2
$366K Sell
4,018
-138
-3% -$12.6K 0.02% 295
2021
Q1
$355K Buy
4,156
+128
+3% +$10.9K 0.02% 287
2020
Q4
$380K Sell
4,028
-194
-5% -$18.3K 0.03% 269
2020
Q3
$367K Sell
4,222
-789
-16% -$68.6K 0.03% 258
2020
Q2
$437K Buy
5,011
+843
+20% +$73.5K 0.04% 237
2020
Q1
$343K Sell
4,168
-1,156
-22% -$95.1K 0.03% 239
2019
Q4
$504K Buy
5,324
+784
+17% +$74.2K 0.04% 212
2019
Q3
$394K Sell
4,540
-204
-4% -$17.7K 0.03% 245
2019
Q2
$433K Sell
4,744
-4,531
-49% -$414K 0.04% 233
2019
Q1
$799K Buy
9,275
+3,963
+75% +$341K 0.07% 142
2018
Q4
$404K Buy
5,312
+166
+3% +$12.6K 0.05% 179
2018
Q3
$397K Hold
5,146
0.04% 200
2018
Q2
$348K Buy
5,146
+163
+3% +$11K 0.04% 210
2018
Q1
$360K Buy
4,983
+412
+9% +$29.8K 0.04% 206
2017
Q4
$343K Sell
4,571
-43
-0.9% -$3.23K 0.04% 212
2017
Q3
$354K Buy
4,614
+205
+5% +$15.7K 0.04% 200
2017
Q2
$329K Sell
4,409
-453
-9% -$33.8K 0.04% 212
2017
Q1
$323K Sell
4,862
-181
-4% -$12K 0.04% 202
2016
Q4
$329K Sell
5,043
-168
-3% -$11K 0.05% 182
2016
Q3
$368K Buy
5,211
+81
+2% +$5.72K 0.06% 168
2016
Q2
$379K Buy
5,130
+56
+1% +$4.14K 0.06% 163
2016
Q1
$329K Buy
5,074
+260
+5% +$16.9K 0.06% 169
2015
Q4
$371K Buy
4,814
+112
+2% +$8.63K 0.08% 146
2015
Q3
$385K Buy
4,702
+1,702
+57% +$139K 0.09% 137
2015
Q2
$264K Buy
3,000
+871
+41% +$76.6K 0.06% 165
2015
Q1
$188K Buy
2,129
+72
+4% +$6.36K 0.08% 138
2014
Q4
$181K Sell
2,057
-832
-29% -$73.2K 0.12% 119
2014
Q3
$240K Sell
2,889
-296
-9% -$24.6K 0.07% 139
2014
Q2
$258K Sell
3,185
-112
-3% -$9.07K 0.07% 145
2014
Q1
$251K Buy
3,297
+338
+11% +$25.7K 0.08% 133
2013
Q4
$213K Sell
2,959
-117
-4% -$8.42K 0.08% 139
2013
Q3
$211K Buy
3,076
+39
+1% +$2.68K 0.08% 140
2013
Q2
$192K Buy
+3,037
New +$192K 0.09% 118